查看购物车
  • Traditional Chinese
  • English
  • Japanese
亚太下一代介入性心臟病学市场：按产品类型、适应症类型、最终用户和国家进行分析和预测（2025-2035 年）
市场调查报告书
商品编码
1800749

亚太下一代介入性心臟病学市场：按产品类型、适应症类型、最终用户和国家进行分析和预测（2025-2035 年）

Asia-Pacific Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 85 Pages | 商品交期: 1-5个工作天内

价格

亚太地区下一代介入性心臟病学市场规模预计将从 2024 年的 53.409 亿美元增至 2035 年的 130.537 亿美元，预测期内的复合年增长率为 8.46%。

新一代介入性心臟病学正在改变亚太地区的心臟护理，该技术采用先进的微创精准引导手术来治疗结构性心臟疾病、冠状动脉疾病和瓣膜疾病。传统的开胸心臟手术显然正在被更安全、更适合患者的导管手术所取代。为了提高安全性、准确性和手术效率，亚太地区的医疗保健专业人员越来越多地利用机器人技术、人工智慧驱动的影像技术和尖端医疗设备技术。这些进步与该地区的医疗重点一致：扩大先进医疗服务的机会、降低治疗成本、并应对与快速老化和人口增长相关的心血管疾病盛行率上升的问题。这些进步也正在改善临床疗效并缩短復原时间。

主要市场统计数据
预测期 2025-2035
2025年评估 56.918亿美元
2035年预测 130.537亿美元
复合年增长率 8.46%

由于心血管疾病发病率的上升以及对微创手术的需求不断增长，该地区的新一代介入性心臟病学市场正在显着扩张。韩国、中国和日本等国人口老化速度加快，加上印度和东南亚地区生活方式相关心臟疾病风险的上升，导致该地区广泛使用先进的导管介入手术来取代传统的开胸心臟手术。

该地区的新一代介入性心臟病学市场正在利用机器人技术、人工智慧增强成像和尖端设备技术来提高准确性、减少併发症并加快康復速度。该地区的医疗保健系统正越来越多地采用药物释放型支架、生物可吸收支架、经导管主动脉瓣置换术(TAVR) 和经导管二尖瓣瓣膜修復(TMVR) 等技术。此外，门诊手术中心、混合导管实验室和数位医疗整合的扩展正在扩大患者获得先进治疗的机会。

世界各国政府正积极推动医疗保健现代化，包括资助计画、优惠的报销制度和基础设施投资。目前，大规模的医院扩建正在进行中，尤其是在中国和印度。儘管医疗保健可近性差异和成本压力等挑战依然存在，但持续的研发投入、全球医疗设备公司与本地公司之间的伙伴关係以及患者意识的不断提升，正使该地区成为下一代介入性心臟病学快速增长的市场。

市场区隔

细分 1：按产品类型

  • 机器人技术
    • 机器人辅助经皮冠状动脉介入治疗（R-PCI）
    • 机器人辅助冠状动脉绕道手术手术（RA-CABG）
    • 机器人辅助二尖瓣置换术（RMVR）
    • 机器人辅助主动脉瓣置换术
  • 非机器人
    • IVUS
    • OCT
    • 其他的
      • 支架
      • 导管
      • 导管导引线
      • PTCA球囊扩张术
      • 其他的

细分2：依适应症类型

  • 结构性心臟疾病
  • 冠状动脉疾病
  • 心臟瓣膜疾病
  • 周边动脉疾病
  • 先天性心臟疾病

细分 3：按最终用户

  • 医院和诊所
  • 心臟中心
  • 门诊手术中心

细分4：按地区

  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 澳洲
    • 韩国
    • 其他的

本报告调查了亚太地区的下一代介入性心臟病学市场，并总结了关键趋势、市场影响因素分析、法律制度、技术和管道趋势、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局和主要企业的概况。

目录

执行摘要

范围和定义

第一章：下一代介入性心臟病学市场：产业展望

  • 竞争格局
    • 商业策略
  • 下一代介入性心臟病学市场：诊断与管理
  • 冠状动脉介入治疗的进展
  • 冠状动脉介入的未来方向和新兴技术
  • 下一代介入性心臟病学市场中的研发线产品
  • 监管状况
    • 亚太地区

第二章 市场动态

  • 趋势
    • 下一代介入性心臟病学市场趋势
  • 市场动态
    • 趋势、驱动因素、挑战和机会：评估当前和未来的影响
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场挑战

3. 下一代介入性心臟病学市场（按地区）

  • 区域摘要
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的

第四章 竞争格局与公司概况

  • 公司简介
    • Terumo Corporation

第五章调查方法

Product Code: BHL3210SS

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Next-Generation Intervention Cardiology Market

The Asia-Pacific next-generation intervention cardiology market is projected to reach $13,053.7 million by 2035 from $5,340.9 million in 2024, growing at a CAGR of 8.46% during the forecast period 2025-2035. Asian-Pacific (APAC) cardiac care is being revolutionized by next-generation interventional cardiology, which uses advanced, minimally invasive, precision-guided procedures to treat structural heart defects, coronary artery disease, and valvular illnesses. Traditional open-heart surgeries are clearly giving way to safer, more patient-specific catheter-based procedures around the region. In order to improve safety, accuracy, and procedural efficiency, healthcare professionals in Asia-Pacific are increasingly utilizing robotics, AI-driven imaging, and cutting-edge gadget technologies. The region's healthcare priorities of increasing access to cutting-edge therapies, lowering treatment costs, and addressing the rising prevalence of cardiovascular diseases in rapidly aging and growing populations are all in line with this advancement, which also improves clinical outcomes and speeds up recovery times.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$5,691.8 Million
2035 Forecast$13,053.7 Million
CAGR8.46%

Market Introduction

The market for next-generation interventional cardiology in Asia-Pacific (APAC) is expanding significantly due to the rising prevalence of cardiovascular illnesses and the growing need for minimally invasive procedures. Advanced catheter-based procedures are becoming more popular in the region as alternatives to traditional open-heart surgeries because to the rapidly aging populations in nations like South Korea, China, and Japan as well as the rising lifestyle-related cardiac risks in India and Southeast Asia.

Robotics, AI-enhanced imaging, and cutting-edge device technologies are all used in APAC's next-generation interventional cardiology to provide increased precision, fewer problems, and quicker recovery. The region's healthcare systems are increasingly implementing technologies including drug-eluting stents, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR). Furthermore, patient access to these cutting-edge treatments is being increased by the rise of ambulatory surgery centers, hybrid cath laboratories, and digital health integration.

With funding programs, advantageous reimbursement practices, and infrastructure expenditures, governments throughout Asia-Pacific are aggressively promoting healthcare modernization. This is especially true in China and India, where massive hospital expansions are currently taking place. While challenges such as disparities in healthcare access and cost pressures persist, continuous R&D efforts, partnerships between global medtech firms and local players, and increasing patient awareness are positioning APAC as a fast-emerging market for next-generation interventional cardiology.

Market Segmentation:

Segmentation 1: By Product Type

  • Robotics
    • Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
    • Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
    • Robotic Assisted Mitral Valve-Replacement (RMVR)
    • Robotic Assisted Aortic Valve Replacement
  • Non-Robotics
    • IVUS
    • OCT
    • Other Interventions
      • Stents
      • Catheters
      • Guidewires
      • PTCA Balloons
      • Others

Segmentation 2: By Indication Type

  • Structural Heart Disease
  • Coronary Heart Diseases
  • Valvular Heart Diseases
  • Peripheral Artery Diseases
  • Congenital Heart Diseases

Segmentation 3: By End User

  • Hospitals and Clinics
  • Cardiac Centers
  • Ambulatory Surgical Centers

Segmentation 4: By Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

APAC Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

  • Rapid shift from open-heart surgery to minimally invasive catheter-based procedures.
  • Growing adoption of robotics, AI-enhanced imaging, and 3D navigation in interventional cardiology.
  • Rising uptake of TAVR (Transcatheter Aortic Valve Replacement), TMVR (Transcatheter Mitral Valve Repair), bioresorbable scaffolds, and drug-coated balloons.
  • Expansion of hybrid cath labs and ambulatory surgical centers across urban and semi-urban regions.
  • Integration of digital health, telecardiology, and remote monitoring into cardiovascular care.
  • Increasing cross-border collaborations between global medtech firms and regional healthcare providers.

Drivers

  • High prevalence of cardiovascular diseases due to aging populations and lifestyle factors (e.g., diabetes, obesity, hypertension).
  • Rising healthcare investments in China, India, Japan, and South Korea to expand advanced cardiology services.
  • Strong push for healthcare modernization through government-funded programs and infrastructure expansion.
  • Growing patient awareness and demand for safer, faster, and less invasive treatment options.
  • Increasing medical tourism in APAC (particularly India, Thailand, and Singapore) for advanced cardiac procedures.

Challenges

  • Healthcare access disparities between urban and rural areas across APAC.
  • High procedure and device costs limiting widespread adoption in developing economies.
  • Complex regulatory environments and approval delays for next-gen medical devices.
  • Shortage of skilled interventional cardiologists and trained staff in emerging markets.
  • Reimbursement gaps and limited insurance coverage for advanced procedures in several countries.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in APAC next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in APAC next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to APAC next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Table of Contents

Executive Summary

Scope and Definition

1 Next-Generation Intervention Cardiology Market: Industry Outlook

  • 1.1 Competitive Landscape
    • 1.1.1 Business Strategies
      • 1.1.1.1 Product Developments in Next-Generation Intervention Cardiology Market
  • 1.2 Next-Generation Intervention Cardiology Market: Diagnosis and Management
  • 1.3 Advancements in Coronary Intervention
  • 1.4 Future Direction and Emerging Technologies in Coronary Interventions
  • 1.5 Pipeline Products in the Next-Generation Intervention Cardiology Market
  • 1.6 Regulatory Landscape
    • 1.6.1 Asia-Pacific
      • 1.6.1.1 Japan
      • 1.6.1.2 China
      • 1.6.1.3 India

2 Market Dynamics

  • 2.1 Trends
    • 2.1.1 Trends in the Next-Generation Intervention Cardiology Market
      • 2.1.1.1 Shift towards Minimally Invasive and Percutaneous Procedures Transforming Treatment Paradigms
      • 2.1.1.2 Integration of AI-Predictive Intelligence in Intervention Cardiology
        • 2.1.1.2.1 AI in Imaging, Lesion Assessment, and Diagnostics
  • 2.2 Market Dynamics
    • 2.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 2.2.2 Market Drivers
      • 2.2.2.1 Rising Elderly Population, Driving Demand for Advanced Cardiac Interventions
        • 2.2.2.1.1 Cardiovascular Disease Burden in the Elderly
      • 2.2.2.2 Emergence of Robotic-Assisted Interventions- Enhancing Procedural Accuracy and Operator Control
    • 2.2.3 Market Restraints
      • 2.2.3.1 High Procedural Cost and Infrastructure Burden Limiting Broad Adoption
      • 2.2.3.2 Regulatory Complexity and Prolonged Approval Timelines Hindering Innovation
        • 2.2.3.2.1 Lengthy Approval Pathways for High-Risk Devices
        • 2.2.3.2.2 Lack of Harmonization across Geographies
        • 2.2.3.2.3 Regulatory Gaps for AI and Software-Driven Devices
    • 2.2.4 Market Opportunities
      • 2.2.4.1 Stent and Balloon Innovation Unlocking Next-Generation Use Cases
        • 2.2.4.1.1 Advancements in Drug-Coated Balloon Technologies
      • 2.2.4.2 Remote and Robotic-Enabled Expansion into Emerging Markets
        • 2.2.4.2.1 Bridging Access Gaps through Remote Robotics
    • 2.2.5 Market Challenges
      • 2.2.5.1 Data Standardization and Clinical Validation Gaps in AI-Driven Cardiology
      • 2.2.5.2 Safety and Clinical Validation Barriers for Next-Generation Vascular Implants

3 Next-Generation Intervention Cardiology Market (Region), Value ($million), 2024-2035

  • 3.1 Regional Summary
  • 3.2 Asia-Pacific
    • 3.2.1 Regional Overview
    • 3.2.2 Driving Factors for Market Growth
    • 3.2.3 Factors Challenging the Market
    • 3.2.4 Japan
    • 3.2.5 China
    • 3.2.6 India
    • 3.2.7 Australia
    • 3.2.8 South Korea
    • 3.2.9 Rest-of-Asia-Pacific

4 Competitive Landscape and Company Profiles

  • 4.1 Company Profiles
    • 4.1.1 Terumo Corporation
      • 4.1.1.1 Overview
      • 4.1.1.2 Top Products/Product Portfolio
      • 4.1.1.3 Top Competitors
      • 4.1.1.4 Target Customers
      • 4.1.1.5 Strategic Positioning and Market Impact
      • 4.1.1.6 Analyst View
      • 4.1.1.7 Pipeline and Research Initiatives

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Inclusion and Exclusion
    • 5.1.4 Data Triangulation
  • 5.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Next-Generation Intervention Cardiology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Next-Generation Intervention Cardiology Market Snapshot
  • Figure 3: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 6: Cardiovascular Disease Statistics
  • Figure 7: Inclusion and Exclusion Criteria for Next-Generation Intervention Cardiology Market
  • Figure 8: Data Triangulation
  • Figure 9: Top-Down and Bottom-Up Approach
  • Figure 10: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pipeline Products in Next-Generation Intervention Cardiology Market
  • Table 3: Next-Generation Intervention Cardiology Market (by Region), $Million, 2024-2035
  • Table 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 6: Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 7: Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 8: Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 9: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 10: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 11: Japan Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 12: Japan Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 13: Japan Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 14: Japan Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 15: Japan Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 16: Japan Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 17: Japan Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 18: China Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 19: China Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 20: China Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 21: China Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 22: China Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 23: China Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 24: China Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 25: India Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 26: India Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 27: India Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 28: India Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 29: India Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 30: India Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 31: India Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 32: Australia Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 33: Australia Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 34: Australia Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 35: Australia Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 36: Australia Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 37: Australia Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 38: Australia Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 39: South Korea Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 40: South Korea Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 41: South Korea Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 42: South Korea Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 43: South Korea Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 44: South Korea Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 45: South Korea Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 46: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 47: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 48: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 49: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 50: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 51: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 52: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035